Search Results
Jul 22, 2026, 08:00 ET Kessler Topaz Meltzer & Check, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of CytoDyn Inc. common stock
www.CytoDynSecuritiesSettlement.com, no later than September 21, 2026, in accordance with the instructions set forth in the Claim Form. If you are a Settlement Class Member and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement, but you will nevertheless
More news about: Kessler Topaz Meltzer & Check, LLP
Jul 22, 2026, 08:00 ET Element Advances Intelligent Mobility with DigiAdvisor, a New AI-Powered Decisioning Tool
Management Discussion and Analysis for the twelve-month period ended December 31, 2025, and under the heading "Risk Factors" in Element's Annual Information Form for the year ended December 31, 2025, which have been filed on SEDAR+ and can be accessed on Element's profile on
More news about: Element Fleet Management Inc.
Jul 22, 2026, 08:00 ET Crystalys Therapeutics Announces $130 Million Series B Financing to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout
impact for patients and also believe in the company's ability to work towards commercialization."About Gout Gout is the most common form of inflammatory arthritis. It is a condition that is very debilitating for patients and characterized by sudden, severe attacks of pain, swelling, redness
More news about: Crystalys Therapeutics
Jul 22, 2026, 08:00 ET Kirin Group and Blackmores to Launch New Cognizin® Cognitive Support Supplements in Australia and New Zealand
society.About Cognizin® CiticolineCognizin® Citicoline, crafted by Kyowa Hakko Bio Co., Ltd., is a clinically validated, patented form of Citicoline, a vital nutrient for brain vitality. Rooted in over 75 years of biotech innovation and Kirin Holdings' century-long fermentation expertise,
More news about: Kyowa Hakko U.S.A
Jul 22, 2026, 08:00 ET Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
sole placement agent for the offering.The securities described above are being offered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-294454) which became effective on March 27, 2026. The Offering is being made only by means of a prospectus which is part of the effective
More news about: DarioHealth Corp.
Jul 22, 2026, 07:45 ET Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway
risks and uncertainties relevant to the company, and other important factors, see Valion Bio's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, under the heading "Risk Factors," as well as the company's subsequent
More news about: Valion Bio, Inc.
Jul 22, 2026, 07:40 ET TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
regarding the timing and likelihood of regulatory approvals; and the other risks described from time to time in detail in Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed on March 31, 2026, and TuHURA's other reports and filings with the SEC from time to time,
More news about: TuHURA Biosciences, Inc.
Jul 22, 2026, 07:30 ET Baidu Provides Update on Voluntary Conversion to Dual-Primary Listing on The Main Board of The Stock Exchange of Hong Kong Limited
accordance with applicable laws and regulations as and when appropriate. This announcement is for information purposes only and does not constitute, or form part of, any invitation or offer to acquire, purchase or subscribe for any securities of the Company. Shareholders and potential investors should exercise
More news about: Baidu, Inc.
Jul 22, 2026, 07:30 ET Auxly Announces 14:1 Share Consolidation
be rounded down to the nearest whole number of Common Shares.The Company's registered shareholders holding their Common Shares in certificated form will receive a letter of transmittal from Computershare Investor Services Inc. ("Computershare"), the Company's transfer agent, in respect to
More news about: Auxly Cannabis Group Inc.
Jul 22, 2026, 07:29 ET Eve Air Mobility and FDOT Partner to Advance Advanced Air Mobility in Florida
Operations of the company's most recent Annual Report on Form 10-K, Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors of the company's most recent Quarterly Report on Form 10-Q, and other risks and uncertainties listed from
More news about: Eve Air Mobility
Jul 22, 2026, 07:07 ET Garmin acquires TrainingPeaks and TrainHeroic, leading endurance and strength training platforms for athletes and coaches
including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 27, 2025, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983). Copies of such Form 10-K are available at
More news about: Garmin Ltd.
Jul 22, 2026, 07:03 ET Tikva Allocell Closes $8 Million Series A Financing to Advance Engineered EBV-Specific T-Cell Therapy for Solid Tumors
further enhanced through Tikva's proprietary protein‑engineering strategies. These cells are equipped with a B7‑H3–targeting receptor and an optimized form of SerpinB9, a natural inhibitor of granzyme B, the enzyme immune cells use to kill their targets. Because a patient's immune system would normally
More news about: Tikva Allocell
Jul 22, 2026, 07:01 ET Iridium Announces Second Quarter 2026 Results
include those factors listed under the caption "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission ("SEC") on February 12, 2026, and the Company's Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on July 22, 2026,
More news about: Iridium Communications Inc.
Jul 22, 2026, 07:00 ET Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
registration statement on Form S-4 that includes a preliminary proxy statement/prospectus of InMed and a management information circular and will file other relevant documents with the SEC and applicable Canadian securities regulators. The Form S-4 has not yet become effective. After the Form S-4 is declared effective,
More news about: Mentari Therapeutics
Jul 22, 2026, 07:00 ET TopGum Advances Longevity with Gummies for Cognition and Vision
of cordyceps, reishi, lion's mane, turkey tail, and six other varieties; a B12 gummy with 1000mcg of methylcobalamin—the highly bioavailable, active form of vitamin vital for nerve health and function. The gummies can be custom designed to meet desired flavors, shapes, colors, and formulations.The
More news about: TopGum Industries, Inc.
Jul 22, 2026, 07:00 ET Graphite One Highlights Strategic Alignment with White House Executive Order Reinforcing U.S. Critical Minerals Supply Chain
economic competitiveness and national security.Graphite One's complete domestic supply chain strategy has received U.S. government support in the form of two Department of War grants – under Defense Production Act authority and from the Defense Logistics Agency – is listed on the Federal Fast-41 permitting
More news about: Graphite One Inc.
Jul 22, 2026, 07:00 ET Sharon AI Appoints Anuj Goel as Chief Financial Officer
forward-looking statements include, among others, all of the risks described in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K filed with the SEC and other reports subsequently filed with the SEC. Additional assumptions, risks and uncertainties are described in detail in
More news about: SharonAI Holdings Inc.
Jul 22, 2026, 07:00 ET OceanaGold Announces Renewal of Share Buyback
risk factors identified and described in more detail in the section entitled "Risk Factors" contained in the Company's most recent Annual Information Form and the Company's other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (the "SEC"), which are available
More news about: OceanaGold Corporation
Jul 22, 2026, 07:00 ET OceanaGold Announces Renewal of Share Buyback
risk factors identified and described in more detail in the section entitled "Risk Factors" contained in the Company's most recent Annual Information Form and the Company's other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (the "SEC"), which are available
More news about: OceanaGold Corporation
Jul 22, 2026, 07:00 ET Curis Announces Positive Emavusertib Update
indicated by forward-looking statements include the factors set forth under the captions "Risk Factor Summary" and "Risk Factors" in our most recent Form 10-K, and the factors that are discussed in other filings that Curis periodically makes with the Securities and Exchange Commission. In addition, any
More news about: Curis, Inc.
Jul 22, 2026, 07:00 ET CME Group Inc. Reports Strong Financial Results for Q2 2026
information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2026, under the caption "Risk
More news about: CME Group
Jul 22, 2026, 06:59 ET Vitamin K2 Market worth $339.9 million by 2031- Exclusive Report by MarketsandMarkets™
Product Type (Protein, Vitamins & Minerals, Superfood & Functional, Prebiotics & Probiotics, Ready-to-Drink (RTD), Snacks), Supplement Form, Age Group, End-use, Distribution Channel, and Region - Global Forecast to 2030
More news about: MarketsandMarkets
Jul 22, 2026, 06:30 ET Zilliant positioned as a Leader in the SPARK Matrix™: B2B Price Optimization & Management, Q4 2025 by QKS Group
competitive positioning. The study also provides a competitive analysis and ranking of the B2B Price Optimization & Management providers in the form of the SPARK Matrix™. The study also provides strategic information for users to evaluate different vendor capabilities, competitive differentiation,
More news about: QKS Group
Jul 22, 2026, 06:30 ET AT&T Delivers Strong Second-Quarter Results as Investment-Led Strategy Gains Momentum
document to the most comparable financial measures under generally accepted accounting principles (GAAP) can be found at investors.att.com and in our Form 8-K dated July 22, 2026. Adjusted diluted EPS, adjusted operating income, EBITDA, EBITDA margin, adjusted EBITDA, free cash flow, and net debt are non-GAAP
More news about: AT&T
Jul 22, 2026, 06:30 ET GoldMining Files PEA Technical Report for its São Jorge Project, Brazil
availability and costs of financing needed in the future. These risks, as well as others, including those set forth in GoldMiningꞌs Annual Information Form for the year ended November 30, 2025, and other filings with Canadian securities regulators and the SEC, could cause actual results and events to vary
More news about: GoldMining Inc.